Single-Cell Regulatory Network Analysis Identifies Adjunctive Drug Candidates in Early Risankizumab-Treated Psoriasis.

Key Points

• Identify potential adjunctive drug candidates for psoriasis treatment using single-cell regulatory network analysis.
• Conducted single-cell regulatory network analysis of psoriasis samples.
• Analyzed drug interaction possibilities with risankizumab treatment.
• Explored the role of specific molecular pathways in psoriasis.
• Identified several promising adjunctive drug candidates for psoriasis.
• Demonstrated the potential for improved treatment outcomes with combination strategies.
• Highlighted molecular targets associated with risankizumab treatment.